ABPCX
Price
$12.27
Change
+$0.01 (+0.08%)
Updated
Jun 25 closing price
Net Assets
87.12M
RLBCX
Price
$35.92
Change
-$0.04 (-0.11%)
Updated
Jun 25 closing price
Net Assets
248.02B
Interact to see
Advertisement

ABPCX vs RLBCX

Header iconABPCX vs RLBCX Comparison
Open Charts ABPCX vs RLBCXBanner chart's image
AB Sustainable Thematic Bal Port C
Price$12.27
Change+$0.01 (+0.08%)
VolumeN/A
Net Assets87.12M
American Funds American Balanced R3
Price$35.92
Change-$0.04 (-0.11%)
VolumeN/A
Net Assets248.02B
ABPCX vs RLBCX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
ABPCX vs. RLBCX commentary
Jun 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ABPCX is a Buy and RLBCX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RLBCX has more cash in the bank: 248B vs. ABPCX (87.1M). RLBCX pays higher dividends than ABPCX: RLBCX (1.63) vs ABPCX (0.08). ABPCX was incepted earlier than RLBCX: ABPCX (22 years) vs RLBCX (23 years). ABPCX (2.00) is less costly to investors than RLBCX (0.89). ABPCX is a more actively managed with annual turnover of: 53.00 vs. RLBCX (44.00). RLBCX has a lower initial minimum investment than ABPCX: RLBCX (250) vs ABPCX (2500). RLBCX annual gain was more profitable for investors over the last year : 6.05 vs. ABPCX (1.32). RLBCX return over 5 years is better than : 39.81 vs. ABPCX (9.82).
ABPCXRLBCXABPCX / RLBCX
Total Expense Ratio1.750.89197%
Annual Report Gross Expense Ratio2.000.89225%
Fund Existence22 years23 years-
Gain YTD1.2395.79621%
Front LoadN/AN/A-
Min. Initial Investment25002501,000%
Min. Initial Investment IRAN/AN/A-
Net Assets87.1M248B0%
Annual Yield % from dividends0.081.635%
Returns for 1 year1.326.0522%
Returns for 3 years14.4630.5547%
Returns for 5 years9.8239.8125%
Returns for 10 years10.8757.7419%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CTRN30.650.29
+0.96%
Citi Trends
IT402.642.25
+0.56%
Gartner
NTLA9.56-0.01
-0.10%
Intellia Therapeutics
VRRM25.01-0.18
-0.71%
Verra Mobility Corp
GBIO0.36-0.01
-1.51%
Generation Bio Co